You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

elotuzumab

Showing 26 - 50 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Newly Diagnosed, Previously Untreated Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Elotuzumab)

Terminated
Has Results
  • Newly Diagnosed, Previously Untreated Multiple Myeloma
  • San Francisco, California
  • +13 more
Jun 29, 2021

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Elotuzumab
  • +5 more
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Mobile, Alabama
  • +21 more
Jun 10, 2021

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Elotuzumab
  • +4 more
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

Multiple Myeloma Trial in United States (Elotuzumab in combination with Lenalidomide and Dexamethasone)

No longer available
  • Multiple Myeloma
  • Elotuzumab in combination with Lenalidomide and Dexamethasone
  • Concord, California
  • +26 more
Mar 17, 2022

Recurrent Primary Amyloidosis Trial in United States (drug, biological, other)

Active, not recruiting
  • Recurrent Primary Amyloidosis
  • Duarte, California
  • +4 more
Mar 10, 2021

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +67 more
Jul 26, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Multiple Myeloma Trial in Little Rock (drug, procedure, biological)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • +4 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 8, 2020

Multiple Myeloma Trial in Germany (elotuzumab, Lenalidomide, Bortezomib)

Completed
  • Multiple Myeloma
  • elotuzumab
  • +3 more
  • Aschaffenburg, Germany
  • +67 more
Sep 9, 2021

Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cells
  • +8 more
  • Freiburg, Baden-Württemberg, Germany
  • +31 more
Jan 5, 2023

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Japanese Patients With Relapse Or Refractory Multiple Myeloma

Completed
  • Multiple Myeloma
  • No Intervention
  • Shinjuku-ku, Tokyo, Japan
    Local Institution
Aug 16, 2019

Multiple Myeloma Trial in Paris (Elotuzumab)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • Paris, France
    Hématologie et thérapie cellulaire, Hôpital Saint Antoine
Jul 15, 2019

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma, Refractory Trial (Pomalidomide 4 mg every day in cycle 1,

Not yet recruiting
  • Multiple Myeloma in Relapse
  • +2 more
  • Pomalidomide 4 mg every day in cycle 1
  • +4 more
  • (no location specified)
Nov 16, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

Completed
  • Multiple Myeloma
  • +7 more
  • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Tucson, Arizona
  • +28 more
Jul 8, 2019

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

Multiple Myeloma Trial in Charlottesville (SLAMF7 BATs)

Not yet recruiting
  • Multiple Myeloma
  • SLAMF7 BATs
  • Charlottesville, Virginia
    University of Virginia
May 17, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Multiple Myeloma Trial in Boston (Dexamethasone, Pomalidomide, Elotuzumab)

Withdrawn
  • Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
Aug 10, 2018

Multiple Myeloma Trial in Little Rock (Elotuzumab, Lenalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jan 25, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021